Protalix Biotherapeutics Inc (PLX) stock is lower by -44.26% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PLX stock a score of 32 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 0. PLX's rank also includes a short-term technical score of 7. The fundamental score for PLX is 88. In addition to the average rating from Wall Street analysts, PLX stock has a mean target price of 9.75. This means analysts expect the stock to rise 377.94% over the next 12 months.
What's Happening with PLX Stock Today
Protalix Biotherapeutics Inc (PLX) stock is trading at $2.04 as of 1:05 PM on Wednesday, Jun 16, a drop of -$0.10, or -4.46% from the previous closing price of $2.13. The stock has traded between $2.02 and $2.13 so far today. Volume today is high. So far 3,656,138 shares have traded compared to average volume of 2,155,377 shares.